Key result
Catheter ablation increases 12-month AF recurrence-free survival vs medical therapy, led by radiofrequency.
Why the study?
Randomized controlled trials directly comparing radiofrequency ablation with cryoballoon ablation as first-line treatment for paroxysmal atrial fibrillation were lacking, motivating a network meta-analysis to evaluate and rank the relative effectiveness of medical therapy, radiofrequency ablation, and cryoballoon ablation.
Does first-line radiofrequency ablation or cryoballoon ablation improve 12-month atrial fibrillation recurrence-free survival compared to medical therapy in patients with paroxysmal atrial fibrillation?
Meta-Analysis
Does first-line radiofrequency ablation or cryoballoon ablation improve 12-month atrial fibrillation recurrence-free survival compared to medical therapy in patients with paroxysmal atrial fibrillation?
This Bayesian network meta-analysis of 5 RCTs demonstrates that both radiofrequency and cryoballoon ablation are significantly more effective than medical therapy as first-line treatment for paroxysmal atrial fibrillation, with radiofrequency ranking highest for 12-month recurrence-free survival.
Answers are grounded in this paper and cite their sources.
Supports first-line ablation over medical therapy in paroxysmal AF; confirms superiority with radiofrequency ranked highest across 5 RCTs.
When multiple treatments are available, network meta-analysis can evaluate data to rank the relative effectiveness. We applied this approach to first-line treatments for paroxysmal atrial fibrillation (medical therapy, radiofrequency ablation or cryoballoon ablation). Individual trials were analysed based on the restricted mean survival time (RMST). Randomised controlled trials (RCT) assessing first-line treatments for paroxysmal atrial fibrillation were referenced from PubMed and the websites of regulatory agencies. The primary end-point was atrial fibrillation recurrence-free survival at 12 months. The treatments assessed for their relative effectiveness were medical therapy, radiofrequency ablation and cryoballoon ablation. Individual trials were examined based on RMST. A Bayesian network meta-analysis was conducted to comparatively evaluate these treatments. Five trials were included in the analysis: two compared radiofrequency with medical treatment and three cryoballoon ablation with medical treatment. The indirect comparison of radiofrequency ablation vs cryoballoon ablation was assessed in the absence of RCTs. Differences in RMST (with 95% credible intervals) were estimated for all binary comparisons (direct or indirect). Radiofrequency and cryoballoon ablation showed significantly increased effectiveness compared with medical treatment. In the indirect comparison, radiofrequency showed a non-significant advantage over cryoballoon ablation. The ranking of effectiveness was as follows: (1) radiofrequency; (2) cryoballoon ablation; (3) medical treatment. In conclusion, we found that radiofrequency was the most effective treatment for paroxysmal atrial fibrillation according to a Bayesian probabilistic model.
No takes yet. Share an insight, caveat, or question.
Messori et al. (2021) conducted a meta-analysis in Paroxysmal atrial fibrillation. Radiofrequency ablation and cryoballoon ablation vs. Medical therapy was evaluated on Atrial fibrillation recurrence-free survival at 12 months evaluated via restricted mean survival time (RMST). Radiofrequency and cryoballoon ablation significantly increased 12-month AF recurrence-free survival vs medical therapy Across 5 RCTs, with radiofrequency ranked first.
Synapse has enriched 10 related papers. Consider them for comparative context: